vaccine, company, pharmaceutical, biotechnology, covid, antibodies, astrazeneca, cambridge, clinical trial, coronavirus, coronavirus vaccine, covid-19, covid19, developer, disease, drug, effective, epidemic, experimental, health, ipo, medical, medicament, medicine, medicines, messenger ribonucleic acid, messenger rna, moderna inc, moderna vaccine, mrna, mrna-1273, outbreak, pandemic, pfizer, pharmacy, pills, price, public, public share offering, research, shares, stocks, syringe, tablet, therapy, treatment, vaccination, virus
